Sanders Machelle

Sanders Machelle is listed in filings as Director at BioCryst Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Nov 17, 2025, including sale activity. Recent filings connect the profile to BioCryst Pharmaceuticals Inc (BCRX) and FORTREA HOLDINGS INC (FTRE). The current snapshot covers public activity from Jun 14, 2024 to Nov 17, 2025. Reported amounts are shown as $68.5K to $28.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.